NATIONAL VISION HOLDINGS INC (EYE)

US63845R1077 - Common Stock

17.88  +0.01 (+0.06%)

After market: 17.88 0 (0%)

Fundamental Rating

3

EYE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 126 industry peers in the Specialty Retail industry. While EYE is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, EYE is valued expensive at the moment.



4

1. Profitability

1.1 Basic Checks

EYE had positive earnings in the past year.
In the past year EYE had a positive cash flow from operations.
EYE had positive earnings in 4 of the past 5 years.
In the past 5 years EYE always reported a positive cash flow from operatings.

1.2 Ratios

EYE has a Return On Assets of -3.03%. This is comparable to the rest of the industry: EYE outperforms 41.27% of its industry peers.
The Return On Equity of EYE (-7.94%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 1.56%, EYE perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for EYE is significantly below the industry average of 13.85%.
Industry RankSector Rank
ROA -3.03%
ROE -7.94%
ROIC 1.56%
ROA(3y)1.46%
ROA(5y)1.51%
ROE(3y)3.52%
ROE(5y)3.76%
ROIC(3y)3.43%
ROIC(5y)3.55%

1.3 Margins

With a Operating Margin value of 1.88%, EYE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of EYE has declined.
The Gross Margin of EYE (52.93%) is better than 83.33% of its industry peers.
EYE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.88%
PM (TTM) N/A
GM 52.93%
OM growth 3Y-34.62%
OM growth 5Y-12.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.69%
GM growth 5Y-0.24%

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EYE is destroying value.
Compared to 1 year ago, EYE has less shares outstanding
The number of shares outstanding for EYE remains at a similar level compared to 5 years ago.
EYE has a better debt/assets ratio than last year.

2.2 Solvency

EYE has an Altman-Z score of 1.83. This is not the best score and indicates that EYE is in the grey zone with still only limited risk for bankruptcy at the moment.
EYE has a Altman-Z score (1.83) which is comparable to the rest of the industry.
EYE has a debt to FCF ratio of 7.92. This is a slightly negative value and a sign of low solvency as EYE would need 7.92 years to pay back of all of its debts.
EYE has a Debt to FCF ratio (7.92) which is in line with its industry peers.
EYE has a Debt/Equity ratio of 0.54. This is a neutral value indicating EYE is somewhat dependend on debt financing.
EYE has a Debt to Equity ratio (0.54) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.92
Altman-Z 1.83
ROIC/WACC0.2
WACC7.96%

2.3 Liquidity

A Current Ratio of 1.00 indicates that EYE may have some problems paying its short term obligations.
With a Current ratio value of 1.00, EYE is not doing good in the industry: 82.54% of the companies in the same industry are doing better.
EYE has a Quick Ratio of 1.00. This is a bad value and indicates that EYE is not financially healthy enough and could expect problems in meeting its short term obligations.
EYE has a Quick ratio (0.70) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.7

4

3. Growth

3.1 Past

EYE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.00%.
EYE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.43% yearly.
Looking at the last year, EYE shows a small growth in Revenue. The Revenue has grown by 6.04% in the last year.
The Revenue has been growing slightly by 6.71% on average over the past years.
EPS 1Y (TTM)0%
EPS 3Y-10.82%
EPS 5Y-2.43%
EPS growth Q2Q75%
Revenue 1Y (TTM)6.04%
Revenue growth 3Y7.5%
Revenue growth 5Y6.71%
Revenue growth Q2Q8%

3.2 Future

The Earnings Per Share is expected to grow by 16.18% on average over the next years. This is quite good.
The Revenue is expected to grow by 0.67% on average over the next years.
EPS Next Y-4.9%
EPS Next 2Y14.4%
EPS Next 3Y16.18%
EPS Next 5YN/A
Revenue Next Year-6.07%
Revenue Next 2Y-3.06%
Revenue Next 3Y0.67%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.31 indicates a quite expensive valuation of EYE.
EYE's Price/Earnings is on the same level as the industry average.
EYE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.92.
With a Price/Forward Earnings ratio of 30.82, EYE can be considered very expensive at the moment.
EYE's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.49, EYE is valued a bit more expensive.
Industry RankSector Rank
PE 29.31
Fwd PE 30.82

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EYE.
EYE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 24.03
EV/EBITDA 12.1

4.3 Compensation for Growth

EYE's earnings are expected to grow with 16.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.4%
EPS Next 3Y16.18%

0

5. Dividend

5.1 Amount

No dividends for EYE!.
Industry RankSector Rank
Dividend Yield N/A

NATIONAL VISION HOLDINGS INC

NASDAQ:EYE (4/26/2024, 7:00:02 PM)

After market: 17.88 0 (0%)

17.88

+0.01 (+0.06%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.40B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 29.31
Fwd PE 30.82
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.03%
ROE -7.94%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.88%
PM (TTM) N/A
GM 52.93%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1
Quick Ratio 0.7
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)0%
EPS 3Y-10.82%
EPS 5Y
EPS growth Q2Q
EPS Next Y-4.9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.04%
Revenue growth 3Y7.5%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y